Raymond James reiterates an Outperform rating on shares of agricultural biotech Ceres (CERE...

|By:, SA News Editor

Raymond James reiterates an Outperform rating on shares of agricultural biotech Ceres (CERE +60.9%), noting that with a $7 price target, now may be an "attractive entry point." The catalyst? Why, the imminent disclosure of "sweet sorghum yields" of course, which is "the key commercialization milestone that the market has been waiting for."